49 unknown. 49 Phase 3, 12 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 49 | Unknown 49 |
| Phase 2 | 12 | Unknown 12 |
Follow Respiratory Hypersensitivity: new trials by email Literature Review of Respiratory Hypersensitivity trials Research Report on Respiratory Hypersensitivity
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy/ Safety of Product CM9241GRU in Patients With Perennial Allergic Rhinitis Product CM9241GRU, Placebo - Rhinitis, Allergic, Perennial | Phase 3 | Unknown | Ache Laboratorios Farmaceuticos S.A. | 432 | 2024-09-01 | 2024-08-29 |
| Efficacy and Safety of MAZ-101 in the Treatment of Persistent Allergic Rhinitis (PER) MAZ-101association, DYMISTA® - Allergic Rhinitis | Phase 3 | Unknown | EMS | 514 | 2024-09-01 | 2024-02-16 |
| Bioequivalence With Clinical Endpoint Study of Fluticasone Propionate 100 mcg and Salmeterol 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 100/50 mcg Inhalation Powder/GSK in Patients With Asthma Fluticasone Propionate 100 mcg and Salmeterol 50 mcg inhalation Powder/Respirent Pharmaceuticals, ADVAIR DISKUS® 100/50 mcg inhalation powder pre-dispensed/GSK, Placebo - Asthma | Phase 3 | Unknown | Respirent Pharmaceuticals Co Ltd. | 451 | 2023-01-30 | 2023-03-01 |
| Efficacy and Safety Evaluation for the Treatment of HDM Induced Allergic Asthma and Rhinitis/Rhinoconjunctivitis MM09 allergoid-mannan conjugates subcutaneous (3.000 UTm/mL), MM09 allergoid-mannan conjugates Sublingual (3.000 UTm/mL), MM09 allergoid-mannan conjugates Sublingual (9.000 UTm/mL) - House Dust Mite Allergy, Perennial Allergic Rhinitis | Phase 3 | Unknown | Inmunotek S.L. | 400 | 2022-12-01 | 2022-11-18 |
| Observation on the Efficacy and Mechanism of SLIT With Dust Mite Allergen for PAR Dust mite drops (trade name: Changdi, Zhejiang Tawu Biotechnology Co. Ltd.). - Allergic Rhinitis | Phase 2 / Phase 3 | Unknown | People's Hospital of Anshun City of Guizhou Province | 60 | 2022-12-01 | 2022-10-06 |
| Efficacy and Safety of Flamboyant 125/12 Association in the Treatment of Adults With Moderate Asthma Flamboyant 125/12, Budesonide/formoterol 200/6, Flamboyant 125/12 Placebo - Asthma | Phase 3 | Unknown | EMS | 134 | 2022-07-22 | 2022-07-27 |
| Efficacy and Safety of Flamboyant 200/12 Association in the Treatment of Adults With Severe Asthma Flamboyant 200/12, Budesonide / Formoterol 400/12, Flamboyant 200/12 Placebo - Asthma | Phase 3 | Unknown | EMS | 134 | 2022-07-22 | 2022-07-27 |
| To Study Generic Fluticasone Propionate Inhalation Aerosol for the Treatment of Bronchial Asthma Fluticasone propionate Inhalation Aerosol 44 mcg, FLOVENT HFA 44 mcg, Matching Placebo inhaler - Bronchial Asthma | Phase 3 | Unknown | Glenmark Pharmaceuticals Ltd. India | 790 | 2022-04-15 | 2022-05-27 |
| Efficacy and Safety Assessment of Beltavac® With Polymerized Extract of HDM House dust mites allergoid from Dermatophagoides pteronyssinus and Dermatophagoides farinae, Placebo - House Dust Mite Allergy | Phase 3 | Unknown | Probelte Pharma S.L.U. | 350 | 2022-01-17 | 2024-07-18 |
| Effect of Sublingual Immunotherapy on Platlet factor4 Level in Children sublingual immunotherapy - Allergic Rhinitis | Phase 3 | Unknown | Zagazig University | 30 | 2021-04-12 | 2021-04-21 |
| Double Dose Magnesium Sulphate in Moderate-severe Asthma in Paediatrics Magnesium Sulfate, Placebo - Asthma in Children | Phase 2 / Phase 3 | Unknown | Oman Medical Speciality Board | 90 | 2020-08-01 | 2020-07-13 |
| Efficacy Of Doxophylline As A Sparing Treatment For Inhaled Corticosteroids In Mexican Children With Asthma Doxophylline, Budesonide - Asthma Chronic, Asthma in Children | Phase 3 | Unknown | Universidad Autonoma de Nuevo Leon | 60 | 2019-05-01 | 2019-03-19 |
| Clinical Efficacy and Safety of Subcutaneous Immunotherapy With gpASIT+™ in Patients With Grass Pollen-induced Allergic Rhinoconjunctivitis Placebo solution, gpASIT+TM - Hay Fever | Phase 3 | Unknown | ASIT Biotech S.A. | 624 | 2019-01-02 | 2018-10-30 |
| A Study to Compare Fluticasone Propionate 100mcg/Salmeterol 50 mcg Inhalation Powder to Advair Discus 100/50 Test Product, Reference Product, Placebo - Asthma | Phase 3 | Unknown | Amneal Ireland Limited | 1204 | 2018-10-01 | 2018-06-20 |
| Bronchoprovocation Study to Evaluate the Pharmacodynamics of Albuterol Sulfate Inhalation Aerosol, eq 90 mcg Base Placebo, 90 mcg Reference Product, 180 mcg Reference Product - Asthma | Phase 3 | Unknown | Amneal Ireland Limited | 100 | 2018-03-16 | 2018-06-14 |
| Traditional Chinese Medicine on Gut Microbiota and Allergic Diseases Bu-Zhong-Yi-Qi-Tang, placebo - Allergic Rhinitis | Phase 3 | Unknown | Chang Gung Memorial Hospital | 60 | 2018-01-10 | 2018-01-26 |
| The Effect of Benralizumab on Exercise-induced Bronchoconstriction Benralizumab - Asthma, Exercise-Induced | Phase 3 | Unknown | Louis-Philippe Boulet | 40 | 2017-12-01 | 2017-10-31 |
| Efficacy of FLUTIFORM ® vs Seretide® in Moderate to Severe Persistent Asthma in Subjects Aged ≥12 Years Fluticasone/ Formoterol, fluticasone/ salmeterol - Asthma | Phase 3 | Unknown | Mundipharma (China) Pharmaceutical Co. Ltd | 330 | 2017-06-02 | 2019-04-29 |
| Salmeterol Xinafoate and Fluticasone Propinate Powder for Inhalation for Asthma Salmeterol Xinafoate and Fluticasone Propinate Powder, Seretide - Asthma | Phase 3 | Unknown | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 300 | 2017-04-01 | 2018-03-12 |
| Efficacy and Safety of So-Cheong-Ryong-Tang on Perennial Allergic Rhinitis SCRT, Placebos - Perennial Allergic Rhinitis | Phase 3 | Unknown | Kyung Hee University Hospital at Gangdong | 154 | 2016-12-31 | 2017-03-14 |
Showing 20 of 49. Sign in to see all of them.
Asthma (27) · Rhinitis, Allergic (13) · Rhinitis, Allergic, Perennial (5) · Rhinitis, Allergic, Seasonal (4) · Hypersensitivity (3) · Conjunctivitis, Allergic (2) · Dust Mite Allergy (2) · Inflammation (2) · Lymphoma, Follicular (2) · Status Asthmaticus (2) · Alveolitis, Extrinsic Allergic (1) · Asthma, Exercise-Induced (1) · Bronchial Hyperreactivity (1) · Dermatitis, Atopic (1) · Eosinophilia (1)
Hypersensitivity, Immediate (49) · Immune System Diseases (49) · Respiratory Tract Diseases (49) · Hypersensitivity (46) · Bronchial Diseases (28) · Lung Diseases (28) · Lung Diseases, Obstructive (26) · Nose Diseases (21) · Otorhinolaryngologic Diseases (21) · Rhinitis (21) · Rhinitis, Allergic (8) · Hemic and Lymphatic Diseases (4) · Pathologic Processes (4) · Pathological Conditions, Signs and Symptoms (4)
Budesonide (5) · Fluticasone-Salmeterol Drug Combination (4) · montelukast (4) · Fluticasone (3) · Allergens (2) · Salmeterol Xinafoate (2) · Sublingual Immunotherapy (2) · dexchlorpheniramine (2) · Albuterol (1) · Antigens, Dermatophagoides (1) · Betamethasone (1) · Breathing Exercises (1) · Bronchial Thermoplasty (1) · Cholecalciferol (1) · Excipients (1)
EMS (4) · Roxall Medizin (4) · Amneal Ireland Limited (2) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (2) · ASIT Biotech S.A. (1) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1) · Ache Laboratorios Farmaceuticos S.A. (1) · Ajou University School of Medicine (1) · Assistance Publique - Hôpitaux de Paris (1) · Chang Gung Memorial Hospital (1) · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (1) · China Medical University Hospital (1) · Cimera (1) · Fundación Pública Andaluza para la gestión de la Investigación en Sevilla (1) · Glenmark Pharmaceuticals Ltd. India (1)
Spain (6) · China (5) · Brazil (4) · United States (4) · Mexico (3) · Germany (2) · India (2) · Taiwan (2) · United Kingdom (2) · Finland (1) · France (1) · Greece (1) · Italy (1) · Japan (1) · Netherlands (1)
Irshad Haque (2) · Alok Nath, MD (1) · Ameet Daftary (1) · Ana Isabel Tabar Purroy, MD. PhD (1) · Andrew Wilson, MD, MRCP (UK) (1) · Aubier Michel (1) · Bachert Claus, Prof Dr (1) · Christopher Corrigan, MD, PhD (1) · Chuanjian Lu, Doctor (1) · Darin Brimhall, DO, FACP (1) · Elisabeth H Bel, MD, PhD (1) · Emmanuelle Dexeus Gabriel Fernandez, pediatrician (1) · Erkki Savilahti, Professor (1)
PMID 36472162, PMID 12668793, PMID 14674933, PMID 15313870, PMID 15461603, PMID 15516669, PMID 15750716, PMID 15898976, PMID 16930249, PMID 17356056, PMID 18331513, PMID 18595980, PMID 19535666, PMID 19726699, PMID 19797480, PMID 19817753, PMID 19925886, PMID 19968632, PMID 20420722, PMID 20525652, PMID 20526242, PMID 20538327, PMID 20545698, PMID 20620566, PMID 20816182, PMID 20870246, PMID 21122901, PMID 21315433, PMID 21771118, PMID 21783242, PMID 21986034, PMID 22093109, PMID 22224763, PMID 22330698, PMID 22361496, PMID 22532985, PMID 22627366, PMID 23348417, PMID 23595876, PMID 23791985, PMID 23792089, PMID 24067388, PMID 24447429, PMID 24506910, PMID 24631153, PMID 24650447, PMID 24679069, PMID 24698320, PMID 24838406, PMID 24989842
2009 (1), 2017 (1)